文献速递神经创伤神经重症

Bio-Shock Index:创伤性脑损伤患者院内死亡预测新工具的提出与依据

Bio-Shock Index: Proposal and Rationale for a New Predictive Tool for In-Hospital Mortality in Patients with Traumatic Brain Injury.
PubMed 文献 · World Neurosurg · 2019-09-07

本研究基于血流动力学参数与生物标志物提出联合休克指数(SI)与高敏肌钙蛋白T(HsTnT)的Bio-Shock Index(Bio-SI),回顾性分析2011—2018年1471例符合纳入标准的TBI患者。高Bio-SI(≥10)占73%,与更差的临床指标、并发症及院内死亡率相关;Bio-SI敏感度91.4%、阴性预测值94.4%,但HsTnT单项优于SI。

要点

  • Bio-SI由休克指数与高敏肌钙蛋白T联合构成,用于预测TBI患者院内死亡。
  • 高Bio-SI(≥10)与更差GCS、更低平均动脉压及更高并发症和院内死亡率相关。
  • Bio-SI敏感度91.4%、阴性预测值94.4%,但HsTnT单项预测优于SI。

核心结论

  • Bio-SI在预测TBI患者院内死亡方面可能优于其各单项成分,但HsTnT单项表现优于SI。
  • 作者认为尚需前瞻性研究和多中心试验验证该新指数的预测能力。

研究设计与样本

  • 回顾性病历审查,时间范围为2011—2018年,对象为创伤性脑损伤患者。
  • 共2619例TBI患者入院,1471例符合纳入标准。
  • 依据受试者工作特征曲线将患者分为低Bio-SI与高Bio-SI两组。

主要发现

  • 73%的患者为高Bio-SI(≥10)。
  • 高Bio-SI与更多脑室内出血(P = 0.001)、脑水肿(P = 0.001)相关。
  • 高Bio-SI组平均动脉压(P = 0.001)、入院GCS评分(P = 0.001)更低,SI(P = 0.001)、血清乳酸(P = 0.001)、HsTnT值(P = 0.001)及Rotterdam评分(P = 0.03)更高。
  • 高Bio-SI组住院时间(P = 0.003)与ICU停留时间(P = 0.001)延长、机械通气天数更多(P = 0.001),肺炎(P = 0.001)、脓毒症(P = 0.001)及院内死亡率(P = 0.001)更高。
  • Bio-SI敏感度91.4%、阴性预测值94.4%; elevated SI分别为50.2%和87.6%;阳性肌钙蛋白分别为79.7%和93.7%。

关键数值与推荐

  • Bio-SI高值定义为≥10(依据ROC曲线确定)。
  • 高Bio-SI组并发症与结局指标均以P = 0.001或P = 0.03报告统计学差异,具体效应量原文未报告。

临床怎么用

  • 可将Bio-SI作为TBI患者入院早期风险分层与院内死亡预警的候选工具。
  • 因HsTnT单项预测优于SI,临床解读时应关注肌钙蛋白与休克指数的各自贡献。
  • 该工具尚未经前瞻性验证,暂不宜替代现有评估体系。

局限性

  • 为单中心回顾性病历审查,存在回顾性研究固有偏倚。
  • 结论需前瞻性研究及纳入结局评分的多中心试验进一步验证。
  • 原文未报告具体效应量、置信区间及多因素校正结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We proposed a novel prognostic tool for the prediction of in-hospital mortality based on a combination of hemodynamic parameters and biomarkers in patients with traumatic brain injury (TBI). We hypothesized that a combination of shock index (SI) with high sensitive troponin T (HsTnT), the Bio-Shock Index (Bio-SI), has better prognostic power than its individual components. METHODS: A retrospective chart review was conducted (2011-2018) for patients with TBI. Patients were categorized into 2 groups (low and high Bio-SI) based on the receiver operating characteristic curve. RESULTS: A total of 2619 patients were admitted with TBI, and 1471 fulfilled the inclusion criteria and 73% had high Bio-SI (≥10). High Bio-SI values were associated with more intraventricular hemorrhage (P = 0.001), brain edema (P = 0.001), and had lower mean arterial pressure (P = 0.001), admission Glasgow Coma Scale score (P = 0.001), and higher SI (P = 0.001), serum lactate (P = 0.001), HsTnT values (P = 0.001), and Rotterdam score (P = 0.03). Patients with high Bio-SI had a prolonged hospital (P = 0.003) and intensive care unit stay (P = 0.001); longer ventilatory days (P = 0.001) and had higher rates of pneumonia (P = 0.001), sepsis (P = 0.001), and in-hospital mortality (P = 0.001). The Bio-SI showed high sensitivity and negative predictive value (91.4% and 94.4%, respectively) as compared with elevated SI (50.2% and 87.6%, respectively) and positive troponin (79.7% and 93.7%, respectively). CONCLUSIONS: The Bio-SI is potentially a better tool than its individual components to predict in-hospital mortality among patients with TBI; however, HsTnT alone outperforms SI. Prospective studies and multicenter trials studying troponin levels and SI in all patients with TBI with the inclusion of outcome scores will prove or disprove the predictability of the new index.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. El-Menyar A, Asim M, Ramzee AF, et al. Bio-Shock Index: Proposal and Rationale for a New Predictive Tool for In-Hospital Mortality in Patients with Traumatic Brain Injury. World Neurosurg. 2019. PMID: 31505291. doi:10.1016/j.wneu.2019.08.229

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。